Cargando…

Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity

Phytoestrogens (PEs) are plant-based compounds that can interact with estrogen receptors and are mainly used to treat menopausal complaints. However, the safety of products with assumed phytoestrogenic activity is not fully understood. This study aimed to identify plant species with assumed phytoest...

Descripción completa

Detalles Bibliográficos
Autores principales: Tjeerdsma, A. Marije, van Hunsel, Florence P. A. M., van de Koppel, Sonja, Ekhart, Corine, Vitalone, Annabella, Woerdenbag, Herman J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459077/
https://www.ncbi.nlm.nih.gov/pubmed/37631050
http://dx.doi.org/10.3390/ph16081137
_version_ 1785097321993732096
author Tjeerdsma, A. Marije
van Hunsel, Florence P. A. M.
van de Koppel, Sonja
Ekhart, Corine
Vitalone, Annabella
Woerdenbag, Herman J.
author_facet Tjeerdsma, A. Marije
van Hunsel, Florence P. A. M.
van de Koppel, Sonja
Ekhart, Corine
Vitalone, Annabella
Woerdenbag, Herman J.
author_sort Tjeerdsma, A. Marije
collection PubMed
description Phytoestrogens (PEs) are plant-based compounds that can interact with estrogen receptors and are mainly used to treat menopausal complaints. However, the safety of products with assumed phytoestrogenic activity is not fully understood. This study aimed to identify plant species with assumed phytoestrogenic activity, review existing literature on their use and safety, and critically evaluate adverse reaction (AR) reports of single-herb, multi-herb, and mixed-multiple products, as submitted to the Netherlands Pharmacovigilance Centre Lareb and to VigiBase of the World Health Organization (WHO). In the Lareb database, the most commonly reported plant species to cause ARs (total of 67 reports) were Actaea racemosa L. (black cohosh) (47.8%), Humulus lupulus L. (hops) (32.8%), and Glycine max (L.) Merr. (soybean) (22.4%). In the VigiBase database (total of 21,944 reports), the top three consisted of Glycine max (L.) Merr. (71.4%), Actaea racemosa L. (11.6%), and Vitex agnus-castus L. (chaste tree) (6.4%). In the scoping review (total of 73 articles), Actaea racemosa L. (30.1%), Glycine max (L.) Merr. (28.8%), and Trifolium pratense L. (13.7%) were the most frequently mentioned plant species. ARs were most frequently reported in the system organ classes “gastrointestinal disorders”, “skin and subcutaneous tissue disorders”, “reproductive system and breast disorders”, and “general disorders and administration site conditions”. Furthermore, from the scoping review, it appeared that the use of products with assumed phytoestrogenic activity was associated with postmenopausal bleeding. It was concluded that, while the potential benefits of products with assumed phytoestrogenic activity have been extensively pursued, the potential occurrence of ARs after using these products is less well understood. This study highlights the need for further investigation and careful monitoring of these products to better understand their effects and ensure the safety and well-being of individuals using them.
format Online
Article
Text
id pubmed-10459077
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104590772023-08-27 Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity Tjeerdsma, A. Marije van Hunsel, Florence P. A. M. van de Koppel, Sonja Ekhart, Corine Vitalone, Annabella Woerdenbag, Herman J. Pharmaceuticals (Basel) Article Phytoestrogens (PEs) are plant-based compounds that can interact with estrogen receptors and are mainly used to treat menopausal complaints. However, the safety of products with assumed phytoestrogenic activity is not fully understood. This study aimed to identify plant species with assumed phytoestrogenic activity, review existing literature on their use and safety, and critically evaluate adverse reaction (AR) reports of single-herb, multi-herb, and mixed-multiple products, as submitted to the Netherlands Pharmacovigilance Centre Lareb and to VigiBase of the World Health Organization (WHO). In the Lareb database, the most commonly reported plant species to cause ARs (total of 67 reports) were Actaea racemosa L. (black cohosh) (47.8%), Humulus lupulus L. (hops) (32.8%), and Glycine max (L.) Merr. (soybean) (22.4%). In the VigiBase database (total of 21,944 reports), the top three consisted of Glycine max (L.) Merr. (71.4%), Actaea racemosa L. (11.6%), and Vitex agnus-castus L. (chaste tree) (6.4%). In the scoping review (total of 73 articles), Actaea racemosa L. (30.1%), Glycine max (L.) Merr. (28.8%), and Trifolium pratense L. (13.7%) were the most frequently mentioned plant species. ARs were most frequently reported in the system organ classes “gastrointestinal disorders”, “skin and subcutaneous tissue disorders”, “reproductive system and breast disorders”, and “general disorders and administration site conditions”. Furthermore, from the scoping review, it appeared that the use of products with assumed phytoestrogenic activity was associated with postmenopausal bleeding. It was concluded that, while the potential benefits of products with assumed phytoestrogenic activity have been extensively pursued, the potential occurrence of ARs after using these products is less well understood. This study highlights the need for further investigation and careful monitoring of these products to better understand their effects and ensure the safety and well-being of individuals using them. MDPI 2023-08-10 /pmc/articles/PMC10459077/ /pubmed/37631050 http://dx.doi.org/10.3390/ph16081137 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tjeerdsma, A. Marije
van Hunsel, Florence P. A. M.
van de Koppel, Sonja
Ekhart, Corine
Vitalone, Annabella
Woerdenbag, Herman J.
Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity
title Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity
title_full Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity
title_fullStr Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity
title_full_unstemmed Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity
title_short Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity
title_sort analysis of safety concerns on herbal products with assumed phytoestrogenic activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459077/
https://www.ncbi.nlm.nih.gov/pubmed/37631050
http://dx.doi.org/10.3390/ph16081137
work_keys_str_mv AT tjeerdsmaamarije analysisofsafetyconcernsonherbalproductswithassumedphytoestrogenicactivity
AT vanhunselflorencepam analysisofsafetyconcernsonherbalproductswithassumedphytoestrogenicactivity
AT vandekoppelsonja analysisofsafetyconcernsonherbalproductswithassumedphytoestrogenicactivity
AT ekhartcorine analysisofsafetyconcernsonherbalproductswithassumedphytoestrogenicactivity
AT vitaloneannabella analysisofsafetyconcernsonherbalproductswithassumedphytoestrogenicactivity
AT woerdenbaghermanj analysisofsafetyconcernsonherbalproductswithassumedphytoestrogenicactivity